GALANTAMINE SR SCP galantamine (as hydrobromide) 16mg modified release capsules blister pack

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Osta kohe

Laadi alla Avaliku hindamisaruande (PAR)
28-11-2017

Toimeaine:

galantamine hydrobromide, Quantity: 20.504 mg (Equivalent: galantamine, Qty 16 mg)

Saadav alates:

Southern Cross Pharma Pty Ltd

INN (Rahvusvaheline Nimetus):

Galantamine hydrobromide

Ravimvorm:

Capsule, modified release

Koostis:

Excipient Ingredients: iron oxide red; ethylcellulose; titanium dioxide; hypromellose; Gelatin; magnesium stearate; microcrystalline cellulose

Manustamisviis:

Oral

Ühikuid pakis:

28

Retsepti tüüp:

(S4) Prescription Only Medicine

Näidustused:

Galantamine is indicated for the treatment of mild to moderately severe dementia of the Alzheimer type

Toote kokkuvõte:

Visual Identification: opaque flesh-flesh size 2 hard gelatin capsule containing two round biconvex tablets; Container Type: Blister Pack; Container Material: PVC/PE/PVDC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2012-01-20